{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T18:46:14Z","timestamp":1793472374982,"version":"4.5.0"},"reference-count":39,"publisher":"American Academy of Pediatrics (AAP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,4,1]]},"abstract":"<jats:p>OBJECTIVE. The goal was to develop multivariate logistic regression models for the outcome of bronchopulmonary dysplasia and\/or death at postmenstrual age of 36 weeks by using clinical and cytokine data from the first 28 days.<\/jats:p><jats:p>METHODS. For 1067 extremely low birth weight infants in the Neonatal Research Network of the National Institute of Child Health and Human Development, levels of 25 cytokines were measured in blood collected within 4 hours after birth and on days 3, 7, 14, and 21. Stepwise regression analyses using peak levels of the 25 cytokines and 15 clinical variables identified variables associated with bronchopulmonary dysplasia\/death. Multivariate logistic regression analysis was performed for bronchopulmonary dysplasia\/death by using variables selected through stepwise regression. Similar analyses were performed by using average cytokine values from days 0 to 21, days 0 to 3, and days 14 to 21.<\/jats:p><jats:p>RESULTS. Of 1062 infants with available data, 606 infants developed bronchopulmonary dysplasia or died. On the basis of results from all models combined, bronchopulmonary dysplasia\/death was associated with higher concentrations of interleukin 1\u03b2, 6, 8, and 10 and interferon \u03b3 and lower concentrations of interleukin 17, regulated on activation, normal T cell expressed and secreted, and tumor necrosis factor \u03b2. Compared with models with only clinical variables, the addition of cytokine data improved predictive ability by a statistically significant but clinically modest magnitude.<\/jats:p><jats:p>CONCLUSIONS. The overall cytokine pattern suggests that bronchopulmonary dysplasia\/death may be associated with impairment in the transition from the innate immune response mediated by neutrophils to the adaptive immune response mediated by T lymphocytes.<\/jats:p>","DOI":"10.1542\/peds.2008-0526","type":"journal-article","created":{"date-parts":[[2009,3,30]],"date-time":"2009-03-30T23:05:24Z","timestamp":1238454324000},"page":"1132-1141","source":"Crossref","is-referenced-by-count":245,"title":["Cytokines Associated With Bronchopulmonary Dysplasia or Death in Extremely Low Birth Weight Infants"],"prefix":"10.1542","volume":"123","author":[{"given":"Namasivayam","family":"Ambalavanan","sequence":"first","affiliation":[{"name":"Department of Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waldemar A.","family":"Carlo","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl T.","family":"D'Angio","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Rochester Medical Center, Rochester, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott A.","family":"McDonald","sequence":"additional","affiliation":[{"name":"Statistics and Epidemiology Unit RTI International, Research Triangle Park, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhik","family":"Das","sequence":"additional","affiliation":[{"name":"Statistics and Epidemiology Unit RTI International, Research Triangle Park, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Schendel","sequence":"additional","affiliation":[{"name":"National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poul","family":"Thorsen","sequence":"additional","affiliation":[{"name":"NANEA Department of Epidemiology Institute of Public Health, University of Aarhus, Aarhus, Denmark; Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosemary D.","family":"Higgins","sequence":"additional","affiliation":[{"name":"Neonatal Research Network, Pregnancy and Perinatology Branch, Center for Developmental Biology and Perinatal Medicine, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2009,4,1]]},"reference":[{"key":"2021120902353697600_R1","doi-asserted-by":"crossref","unstructured":"Fanaroff AA, Stoll BJ, Wright LL, et al. Trends in neonatal morbidity and mortality for very low birthweight infants. Am J Obstet Gynecol.\u20082007;196(2):147.e1\u2013147.e8","DOI":"10.1016\/j.ajog.2006.09.014"},{"key":"2021120902353697600_R2","doi-asserted-by":"crossref","unstructured":"Ambalavanan N, Carlo WA. Bronchopulmonary dysplasia: new insights. Clin Perinatol.\u20082004;31(3):613\u2013628","DOI":"10.1016\/j.clp.2004.05.003"},{"key":"2021120902353697600_R3","doi-asserted-by":"crossref","unstructured":"Goodman RB, Pugin J, Lee JS, Matthay MA. Cytokine-mediated inflammation in acute lung injury. Cytokine Growth Factor Rev.\u20082003;14(6):523\u2013535","DOI":"10.1016\/S1359-6101(03)00059-5"},{"key":"2021120902353697600_R4","doi-asserted-by":"crossref","unstructured":"Belperio JA, Keane MP, Lynch JP III, Strieter RM. The role of cytokines during the pathogenesis of ventilator-associated and ventilator-induced lung injury. Semin Respir Crit Care Med.\u20082006;27(4):350\u2013364","DOI":"10.1055\/s-2006-948289"},{"key":"2021120902353697600_R5","doi-asserted-by":"crossref","unstructured":"Strieter RM, Belperio JA, Keane MP. Cytokines in innate host defense in the lung. J Clin Invest.\u20082002;109(6):699\u2013705","DOI":"10.1172\/JCI0215277"},{"key":"2021120902353697600_R6","doi-asserted-by":"crossref","unstructured":"Kotecha S, Wilson L, Wangoo A, Silverman M, Shaw RJ. Increase in interleukin (IL)-1\u03b2 and IL-6 in bronchoalveolar lavage fluid obtained from infants with chronic lung disease of prematurity. Pediatr Res.\u20081996;40(2):250\u2013256","DOI":"10.1203\/00006450-199608000-00010"},{"key":"2021120902353697600_R7","doi-asserted-by":"crossref","unstructured":"Baier RJ, Majid A, Parupia H, Loggins J, Kruger TE. CC chemokine concentrations increase in respiratory distress syndrome and correlate with development of bronchopulmonary dysplasia. Pediatr Pulmonol.\u20082004;37(2):137\u2013148","DOI":"10.1002\/ppul.10417"},{"key":"2021120902353697600_R8","doi-asserted-by":"crossref","unstructured":"Vento G, Capoluongo E, Matassa PG, et al. Serum levels of seven cytokines in premature ventilated newborns: correlations with old and new forms of bronchopulmonary dysplasia. Intensive Care Med.\u20082006;32(5):723\u2013730","DOI":"10.1007\/s00134-006-0138-1"},{"key":"2021120902353697600_R9","doi-asserted-by":"crossref","unstructured":"Viscardi RM, Muhumuza CK, Rodriguez A, et al. Inflammatory markers in intrauterine and fetal blood and cerebrospinal fluid compartments are associated with adverse pulmonary and neurologic outcomes in preterm infants. Pediatr Res.\u20082004;55(6):1009\u20131017","DOI":"10.1203\/01.pdr.0000127015.60185.8a"},{"key":"2021120902353697600_R10","doi-asserted-by":"crossref","unstructured":"Skogstrand K, Thorsen P, N\u00f8rgaard-Pedersen P, et al. Simultaneous determination of 25 inflammatory markers and neurotrophins in neonatal dried blood spots by immunoassay xMAP technology. Clin Chem.\u20082005;51(10):1854\u20131866","DOI":"10.1373\/clinchem.2005.052241"},{"key":"2021120902353697600_R11","doi-asserted-by":"crossref","unstructured":"Skogstrand K, Ekelund CK, Thorsen P, et al. Effects of blood sample handling procedures on measurable inflammatory markers in plasma, serum and dried blood spot samples. J Immunol Methods.\u20082008;336(1):78\u201384","DOI":"10.1016\/j.jim.2008.04.006"},{"key":"2021120902353697600_R12","doi-asserted-by":"crossref","unstructured":"Bhandari V, Bizzarro MJ, Shetty A, et al. Familial and genetic susceptibility to major neonatal morbidities in preterm twins. Pediatrics.\u20082006;117(6):1901\u20131906","DOI":"10.1542\/peds.2005-1414"},{"key":"2021120902353697600_R13","doi-asserted-by":"crossref","unstructured":"Lucey DR, Clerici M, Shearer GM. Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases. Clin Microbiol Rev.\u20081996;9(4):532\u2013562","DOI":"10.1128\/CMR.9.4.532"},{"key":"2021120902353697600_R14","doi-asserted-by":"crossref","unstructured":"Gasparoni A, Ciardelli L, Avanzini A, et al. Age-related changes in intracellular TH1\/TH2 cytokine production, immunoproliferative T lymphocyte response and natural killer cell activity in newborns, children and adults. Biol Neonate.\u20082003;84(4):297\u2013303","DOI":"10.1159\/000073638"},{"key":"2021120902353697600_R15","doi-asserted-by":"crossref","unstructured":"Dinarello CA. Biologic basis for interleukin-1 in disease. Blood.\u20081996;87(6):2095\u20132147","DOI":"10.1182\/blood.V87.6.2095.bloodjournal8762095"},{"key":"2021120902353697600_R16","doi-asserted-by":"crossref","unstructured":"Ley K, Smith E, Stark MA. IL-17A-producing neutrophil-regulatory Tn lymphocytes. Immunol Res.\u20082006;34(3):229\u2013242","DOI":"10.1385\/IR:34:3:229"},{"key":"2021120902353697600_R17","doi-asserted-by":"crossref","unstructured":"Park H, Li Z, Yang XO, et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol.\u20082005;6(11):1133\u20131141","DOI":"10.1038\/ni1261"},{"key":"2021120902353697600_R18","doi-asserted-by":"crossref","unstructured":"Numasaki M, Fukushi J, Ono M, et al. Interleukin-17 promotes angiogenesis and tumor growth. Blood.\u20082003;101(7):2620\u20132627","DOI":"10.1182\/blood-2002-05-1461"},{"key":"2021120902353697600_R19","doi-asserted-by":"crossref","unstructured":"Jakkula M, Le Cras TD, Gebb S, et al. Inhibition of angiogenesis decreases alveolarization in the developing rat lung. Am J Physiol Lung Cell Mol Physiol.\u20082000;279(3):L600\u2013L607","DOI":"10.1152\/ajplung.2000.279.3.L600"},{"key":"2021120902353697600_R20","doi-asserted-by":"crossref","unstructured":"Yamada M, Kubo H, Kobayashi S, Ishizawa K, Sasaki H. Interferon-\u03b3: a key contributor to hyperoxia-induced lung injury in mice. Am J Physiol Lung Cell Mol Physiol.\u20082004;287(5):L1042\u2013L1047","DOI":"10.1152\/ajplung.00155.2004"},{"key":"2021120902353697600_R21","doi-asserted-by":"crossref","unstructured":"Wang Z, Zheng T, Zhu Z, et al. Interferon \u03b3 induction of pulmonary emphysema in the adult murine lung. J Exp Med.\u20082000;192(11):1587\u20131600","DOI":"10.1084\/jem.192.11.1587"},{"key":"2021120902353697600_R22","doi-asserted-by":"crossref","unstructured":"Jiang D, Liang J, Hodge J, et al. Regulation of pulmonary fibrosis by chemokine receptor CXCR3. J Clin Invest.\u20082004;114(2):291\u2013299","DOI":"10.1172\/JCI16861"},{"key":"2021120902353697600_R23","unstructured":"Howard MC, Miyajima A, Coffmann R. T-cell-derived cytokines and their receptors. In: Paul WE, ed. Fundamental Immunology. 3rd ed. New York, NY: Raven Press; 1993:763\u2013800"},{"key":"2021120902353697600_R24","doi-asserted-by":"crossref","unstructured":"Aggarwal BB. Signalling pathways of the TNF superfamily: a double-edged sword. Nat Rev Immunol.\u20082003;3(9):745\u2013756","DOI":"10.1038\/nri1184"},{"key":"2021120902353697600_R25","doi-asserted-by":"crossref","unstructured":"Mukaida N. Pathophysiological roles of interleukin-8\/CXCL8 in pulmonary diseases. Am J Physiol Lung Cell Mol Physiol.\u20082003;284(4):L566\u2013L577","DOI":"10.1152\/ajplung.00233.2002"},{"key":"2021120902353697600_R26","doi-asserted-by":"crossref","unstructured":"Parsons PE, Eisner MD, Thompson BT, et al. Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury. Crit Care Med.\u20082005;33(1):1\u20136","DOI":"10.1097\/01.CCM.0000149854.61192.DC"},{"key":"2021120902353697600_R27","doi-asserted-by":"crossref","unstructured":"Appay V, Rowland-Jones SL. RANTES: a versatile and controversial chemokine. Trends Immunol.\u20082001;22(2):83\u201387","DOI":"10.1016\/S1471-4906(00)01812-3"},{"key":"2021120902353697600_R28","doi-asserted-by":"crossref","unstructured":"Song A, Nikolcheva T, Krensky AM. Transcriptional regulation of RANTES expression in T lymphocytes. Immunol Rev.\u20082000;177:236\u2013245","DOI":"10.1034\/j.1600-065X.2000.17610.x"},{"key":"2021120902353697600_R29","doi-asserted-by":"crossref","unstructured":"Robertson MJ. Role of chemokines in the biology of natural killer cells. J Leukoc Biol.\u20082002;71(2):173\u2013183","DOI":"10.1189\/jlb.71.2.173"},{"key":"2021120902353697600_R30","doi-asserted-by":"crossref","unstructured":"Galkina E, Thatte J, Dabak V, Williams MB, Ley K, Braciale TJ. Preferential migration of effector CD8+ T cells into the interstitium of the normal lung. J Clin Invest.\u20082005;115(12):3473\u20133483","DOI":"10.1172\/JCI24482"},{"key":"2021120902353697600_R31","doi-asserted-by":"crossref","unstructured":"Liu H, Chao D, Nakayama EE, et al. Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression. Proc Natl Acad Sci U S A.\u20081999;96(8):4581\u20134585","DOI":"10.1073\/pnas.96.8.4581"},{"key":"2021120902353697600_R32","doi-asserted-by":"crossref","unstructured":"Nickel RG, Casolaro V, Wahn U, et al. Atopic dermatitis is associated with a functional mutation in the promoter of the C-C chemokine RANTES. J Immunol.\u20082000;164(3):1612\u20131616","DOI":"10.4049\/jimmunol.164.3.1612"},{"key":"2021120902353697600_R33","doi-asserted-by":"crossref","unstructured":"Oberholzer A, Oberholzer C, Moldawer LL. Interleukin-10: a complex role in the pathogenesis of sepsis syndromes and its potential as an anti-inflammatory drug. Crit Care Med.\u20082002;30(1 suppl):S58\u2013S63","DOI":"10.1097\/00003246-200201001-00008"},{"key":"2021120902353697600_R34","doi-asserted-by":"crossref","unstructured":"Parsons PE, Moss M, Vannice JL, Moore EE, Moore FA, Repine JE. Circulating IL-1ra and IL-10 levels are increased but do not predict the development of acute respiratory distress syndrome in at-risk patients. Am J Respir Crit Care Med.\u20081997;155(4):1469\u20131473","DOI":"10.1164\/ajrccm.155.4.9105096"},{"key":"2021120902353697600_R35","doi-asserted-by":"crossref","unstructured":"Garingo A, Tesoriero L, Cayabyab R, et al. Constitutive IL-10 expression by lung inflammatory cells and risk for bronchopulmonary dysplasia. Pediatr Res.\u20082007;61(2):197\u2013202","DOI":"10.1203\/pdr.0b013e31802d8a1c"},{"key":"2021120902353697600_R36","doi-asserted-by":"crossref","unstructured":"Kishimoto T. Interleukin-6: discovery of a pleiotropic cytokine. Arthritis Res Ther.\u20082006;8(suppl 2):S2","DOI":"10.1186\/ar1916"},{"key":"2021120902353697600_R37","doi-asserted-by":"crossref","unstructured":"Gabay C. Interleukin-6 and chronic inflammation. Arthritis Res Ther.\u20082006;(8 suppl 2):S3","DOI":"10.1186\/ar1917"},{"key":"2021120902353697600_R38","doi-asserted-by":"crossref","unstructured":"Smolen JS, Maini RN. Interleukin-6: a new therapeutic target. Arthritis Res Ther.\u20082006;8(suppl 2):S5","DOI":"10.1186\/ar1969"},{"key":"2021120902353697600_R39","doi-asserted-by":"crossref","unstructured":"Yamagata T, Ichinose M. Agents against cytokine synthesis or receptors. Eur J Pharmacol.\u20082006;533(1\u20133):289\u2013301","DOI":"10.1016\/j.ejphar.2005.12.046"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/123\/4\/1132\/1022752\/zpe00409001132.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/123\/4\/1132\/1022752\/zpe00409001132.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T17:53:00Z","timestamp":1684950780000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/123\/4\/1132\/71391\/Cytokines-Associated-With-Bronchopulmonary"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4,1]]},"references-count":39,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2009,4,1]]},"published-print":{"date-parts":[[2009,4,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2008-0526","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4,1]]}}}